StopDownOpen the app

Funding · Healthcare & Life Sciences

Zanskar in talks to raise ~$6 Mn led by Bessemer

By ·

Date
Company
Zanskar
What it does
Tech-led pain management platform
Kind
Funding
Amount
$6 Mn
Stage
Series A
Founded
2022
Sector
Healthcare & Life Sciences

What they do

Zanskar is a tech-led pain management platform offering at-home care protocols and products

What happened

The company is in talks to raise approximately $6 million in a fresh round led by Bessemer Venture Partners

Why it matters

This investment highlights growing interest in chronic pain management startups despite muted overall healthtech funding activity

The details

  • Zanskar is currently in talks to raise a new funding round of approximately $6 million.
  • The fresh capital raise is being led by Bessemer Venture Partners as the primary investor.
  • Discussions are ongoing with the final cheque size remaining subject to change before the deal closes.
  • Both Zanskar and Bessemer did not respond to Inc42 queries at the time of publication.
  • This follows a previous seed round of ₹2.8 crore raised roughly ten months prior to this event.
  • Investor interest in chronic pain management startups is reportedly growing significantly in the current market.
  • The broader healthtech market is projected to cross $37 billion by 2030 with a high growth rate.
  • Overall funding activity in the sector has seen a decline with deals falling to 54 in 2025.

The bigger picture

  • Untreated chronic pain or prolonged reliance on painkillers can lead to serious disability and complications.
  • A significant portion of the Indian population suffers from joint and back pain issues.
  • Competitors like Nivaan Care and FlexifyMe have recently secured substantial funding for similar models.

About the business

  • Zanskar operates as a tech-led pain management platform accessible primarily through its mobile application.
  • The company offers personalised at-home care protocols designed to manage pain without hospital visits.
  • It sells physical pain relief products including oils, roll-ons, and nutritional supplements directly to consumers.
  • Sales channels include its own website and major e-commerce platforms like Amazon and Flipkart.
  • Products are also available on quick commerce apps like Blinkit and health platforms like Tata 1mg.
  • The founders are exploring pilots for physiotherapy-led wellness centres in select metro cities.
  • The business model combines digital care protocols with physical product sales for revenue generation.
  • Co-founders Anshul Mittal and Manu Kumar Mittal established the company in 2022 after graduating from IIT Delhi.

What happens next

  • Zanskar is exploring pilots for physiotherapy-led wellness centres in select metro cities.

The deal

Type
Series A

Investors

  • Bessemer Venture Partners (lead) — Global venture capital firm leading the fresh round discussions.
  • Zeropearl VC (existing) — Led the previous seed round of ₹2.8 crore ten months prior.
  • Pawan Gupta (existing) — Co-founder of Fashinza who participated in the seed round.
  • Amit Baid (existing) — Managing Partner at 10X Growth Ventures who participated in the seed round.
  • Nidhish Mundra (existing) — SVP at Oaktree Capital who participated in the seed round.

Founders

  • Anshul Mittal, co-founder
  • Manu Kumar Mittal, co-founder

About Zanskar

Product
based pain care startup
Customers
Consumers seeking pain relief and at-home care for joint pain, migraines, arthritis, and muscle recovery
How it makes money
Sells pain-relief products online and offers a technology-led pain management app with personalised at-home care protocols
What sets it apart
Combines products with an AI-driven physiotherapy app and personalised home-care protocols

Read it as a card in the app

More on Zanskar

Everything on Zanskar →

Same day

All startup news on 5 August 2026 →